See how advanced analytics are driving the next generation of compliance risk management programs. In this video, Bristol Myers Squibb (BMS) leaders join ZS's head of global risk and compliance, Michael Shaw, to discuss how advanced analytics models could help pharma support compliance programs by assessing the feasibility of generating risk-based insights. Watch our webinar to learn:
- Quick wins that offer immediate risk mitigation value
- How to build credibility with the business by identifying the value and risk associated with key business activities
- How advanced analytics helped a pharma company triangulate data to deliver risk profiles by market, therapeutic area and individuals
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.